Green FR - Search Results

1

The 4G/5G genetic polymorphism in the promoter of the plasminogen activator inhibitor-1 (PAI-1) gene is associated with differences in plasma PAI-1 activity but not with risk of myocardial infarction in the ECTIM study. Etude CasTemoins de I'nfarctus du Mycocarde.

Ye S, Green FR, Scarabin PY, Nicaud V, Bara L, Dawson SJ, Humphries SE, Evans A, Luc G, Cambou JP, et al. Ye S, et al. Among authors: green fr. Thromb Haemost. 1995 Sep;74(3):837-41. Thromb Haemost. 1995. PMID: 8571307

2

Determinants of plasminogen activator inhibitor 1 activity in treated NIDDM and its relation to a polymorphism in the plasminogen activator inhibitor 1 gene.

Panahloo A, Mohamed-Ali V, Lane A, Green F, Humphries SE, Yudkin JS. Panahloo A, et al. Diabetes. 1995 Jan;44(1):37-42. doi: 10.2337/diab.44.1.37. Diabetes. 1995. PMID: 7813812 Clinical Trial.

3

Genetic determinants of arterial thrombosis.

Green F, Humphries S. Green F, et al. Baillieres Clin Haematol. 1994 Sep;7(3):675-92. doi: 10.1016/s0950-3536(05)80103-9. Baillieres Clin Haematol. 1994. PMID: 7841605 Review.

4

The role of beta-fibrinogen genotype in determining plasma fibrinogen levels in young survivors of myocardial infarction and healthy controls from Sweden.

Green F, Hamsten A, Blombäck M, Humphries S. Green F, et al. Thromb Haemost. 1993 Dec 20;70(6):915-20. Thromb Haemost. 1993. PMID: 8165611

5

The two allele sequences of a common polymorphism in the promoter of the plasminogen activator inhibitor-1 (PAI-1) gene respond differently to interleukin-1 in HepG2 cells.

Dawson SJ, Wiman B, Hamsten A, Green F, Humphries S, Henney AM. Dawson SJ, et al. J Biol Chem. 1993 May 25;268(15):10739-45. J Biol Chem. 1993. PMID: 8388372 Free article.

6

Low plasma levels of factor VIIc and antigen are more strongly associated with the 10 base pair promoter (-323) insertion than the glutamine 353 variant.

Humphries S, Temple A, Lane A, Green F, Cooper J, Miller G. Humphries S, et al. Thromb Haemost. 1996 Apr;75(4):567-72. Thromb Haemost. 1996. PMID: 8743180 Clinical Trial.

7

Factor VII Arg/Gln353 polymorphism determines factor VII coagulant activity in patients with myocardial infarction (MI) and control subjects in Belfast and in France but is not a strong indicator of MI risk in the ECTIM study.

Lane A, Green F, Scarabin PY, Nicaud V, Bara L, Humphries S, Evans A, Luc G, Cambou JP, Arveiler D, Cambien F. Lane A, et al. Atherosclerosis. 1996 Jan 5;119(1):119-27. doi: 10.1016/0021-9150(95)05638-6. Atherosclerosis. 1996. PMID: 8929253

8

Gene-environment interaction in the determination of levels of haemostatic variables involved in thrombosis and fibrinolysis.

Humphries SE, Panahloo A, Montgomery HE, Green F, Yudkin J. Humphries SE, et al. Thromb Haemost. 1997 Jul;78(1):457-61. Thromb Haemost. 1997. PMID: 9198196 Review.

9

The study of gene-environment interactions that influence thrombosis and fibrinolysis. Genetic variation at the loci for factor VII and plasminogen activator inhibitor-1.

Humphries SE, Lane A, Dawson S, Green FR. Humphries SE, et al. Among authors: green fr. Arch Pathol Lab Med. 1992 Dec;116(12):1322-9. Arch Pathol Lab Med. 1992. PMID: 1456879 Review.

10

Variation in the promoter region of the beta fibrinogen gene is associated with plasma fibrinogen levels in smokers and non-smokers.

Thomas AE, Green FR, Kelleher CH, Wilkes HC, Brennan PJ, Meade TW, Humphries SE. Thomas AE, et al. Among authors: green fr. Thromb Haemost. 1991 May 6;65(5):487-90. Thromb Haemost. 1991. PMID: 1871708

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

71 results

Search Page

Filters